Coexpression cluster:C896: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 5: | Line 5: | ||
|id=C896 | |id=C896 | ||
|kegg_enrichment=hsa03040;Spliceosome;4.36E-07 | |kegg_enrichment=hsa03040;Spliceosome;4.36E-07 | ||
|ontology_enrichment_celltype= | |ontology_enrichment_celltype=CL:0000548!3.05e-21!679;CL:0000255!3.05e-21!679;CL:0000066!1.07e-15!253;CL:0000003!9.21e-15!722;CL:0002321!3.53e-08!250 | ||
|ontology_enrichment_disease=DOID: | |ontology_enrichment_disease=DOID:14566!2.60e-54!239;DOID:162!2.82e-54!235;DOID:0050686!8.23e-27!137;DOID:0050687!3.65e-26!143;DOID:305!2.49e-22!106;DOID:2531!4.15e-21!51;DOID:0060083!4.15e-21!51;DOID:1240!4.55e-17!39;DOID:8692!3.40e-13!31 | ||
|ontology_enrichment_uberon= | |ontology_enrichment_uberon= | ||
|pathway_enrichment=3.49156482482783e-06;0.000736720178038672;3;134;mRNA processing (Wikipathways):WP1863!1.57612000639245e-06;0.000498841982023211;4;421;Gene Expression (Reactome):REACT_71!4.7073957674912e-06;0.000744945380205483;3;148;mRNA Processing (Reactome):REACT_1675!7.12387426768043e-08;4.50941241144171e-05;4;194;{POLR2A,195} (Static Module):NA | |pathway_enrichment=3.49156482482783e-06;0.000736720178038672;3;134;mRNA processing (Wikipathways):WP1863!1.57612000639245e-06;0.000498841982023211;4;421;Gene Expression (Reactome):REACT_71!4.7073957674912e-06;0.000744945380205483;3;148;mRNA Processing (Reactome):REACT_1675!7.12387426768043e-08;4.50941241144171e-05;4;194;{POLR2A,195} (Static Module):NA |
Revision as of 16:50, 19 October 2012
Full id: C896_retinoblastoma_iPS_acute_lymphoma_chronic_Burkitt_testicular
Phase1 CAGE Peaks
Hg19::chr12:54674482..54674520,+ | p1@HNRNPA1 |
Hg19::chr14:64855014..64855091,+ | p1@MTHFD1 |
Hg19::chr18:19192235..19192337,+ | p1@SNRPD1 |
Hg19::chr1:54303949..54303979,- | p1@TMEM48 |
Hg19::chr2:9563769..9563832,+ | p1@CPSF3 |
Hg19::chr4:57301896..57301945,+ | p3@PAICS |
Hg19::chr4:57302399..57302441,+ | p1@PAICS |
Hg19::chr6:8102752..8102806,- | p1@EEF1E1 |
Hg19::chr8:4644826..4644848,+ | p1@PAICSP4 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
p.value | FDR | nGenes | nPathway | Name |
---|---|---|---|---|
3.49156482482783e-06 | 0.000736720178038672 | 3 | 134 | mRNA processing (Wikipathways):WP1863 |
1.57612000639245e-06 | 0.000498841982023211 | 4 | 421 | Gene Expression (Reactome):REACT_71 |
4.7073957674912e-06 | 0.000744945380205483 | 3 | 148 | mRNA Processing (Reactome):REACT_1675 |
7.12387426768043e-08 | 4.50941241144171e-05 | 4 | 194 | {POLR2A,195} (Static Module):NA |
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0006397 | mRNA processing | 0.00271301856430786 |
GO:0016071 | mRNA metabolic process | 0.00271301856430786 |
GO:0044428 | nuclear part | 0.00271301856430786 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 0.00271301856430786 |
GO:0000375 | RNA splicing, via transesterification reactions | 0.00271301856430786 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 0.00271301856430786 |
GO:0051028 | mRNA transport | 0.00271301856430786 |
GO:0006396 | RNA processing | 0.00271301856430786 |
GO:0050658 | RNA transport | 0.00271301856430786 |
GO:0051236 | establishment of RNA localization | 0.00271301856430786 |
GO:0050657 | nucleic acid transport | 0.00271301856430786 |
GO:0006403 | RNA localization | 0.00271301856430786 |
GO:0015931 | nucleobase, nucleoside, nucleotide and nucleic acid transport | 0.00271301856430786 |
GO:0051292 | nuclear pore complex assembly | 0.00271301856430786 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 0.00271301856430786 |
GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator | 0.00271301856430786 |
GO:0031081 | nuclear pore distribution | 0.00271301856430786 |
GO:0051664 | nuclear pore localization | 0.00271301856430786 |
GO:0046483 | heterocycle metabolic process | 0.00375888651171585 |
GO:0005681 | spliceosome | 0.00408093417500499 |
GO:0006999 | nuclear pore organization and biogenesis | 0.00465047824450652 |
GO:0006164 | purine nucleotide biosynthetic process | 0.00484923975527564 |
GO:0006163 | purine nucleotide metabolic process | 0.00505093545520049 |
GO:0006725 | aromatic compound metabolic process | 0.00505093545520049 |
GO:0004638 | phosphoribosylaminoimidazole carboxylase activity | 0.00505093545520049 |
GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity | 0.00505093545520049 |
GO:0031503 | protein complex localization | 0.00505093545520049 |
GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity | 0.00505093545520049 |
GO:0009320 | phosphoribosylaminoimidazole carboxylase complex | 0.00505093545520049 |
GO:0003723 | RNA binding | 0.00601224402120285 |
GO:0004486 | methylenetetrahydrofolate dehydrogenase activity | 0.00610267470704545 |
GO:0004639 | phosphoribosylaminoimidazolesuccinocarboxamide synthase activity | 0.00610267470704545 |
GO:0008380 | RNA splicing | 0.00641648721647463 |
GO:0044237 | cellular metabolic process | 0.00641648721647463 |
GO:0046040 | IMP metabolic process | 0.00641648721647463 |
GO:0006189 | 'de novo' IMP biosynthetic process | 0.00641648721647463 |
GO:0016155 | formyltetrahydrofolate dehydrogenase activity | 0.00641648721647463 |
GO:0006188 | IMP biosynthetic process | 0.00641648721647463 |
GO:0044238 | primary metabolic process | 0.00641648721647463 |
GO:0009165 | nucleotide biosynthetic process | 0.00681108494481145 |
GO:0000105 | histidine biosynthetic process | 0.00681108494481145 |
GO:0009076 | histidine family amino acid biosynthetic process | 0.00681108494481145 |
GO:0019238 | cyclohydrolase activity | 0.00681108494481145 |
GO:0009113 | purine base biosynthetic process | 0.00742737510308045 |
GO:0017056 | structural constituent of nuclear pore | 0.00742737510308045 |
GO:0048584 | positive regulation of response to stimulus | 0.00742737510308045 |
GO:0006379 | mRNA cleavage | 0.00808909795120509 |
GO:0043231 | intracellular membrane-bound organelle | 0.00808909795120509 |
GO:0043227 | membrane-bound organelle | 0.00808909795120509 |
GO:0006378 | mRNA polyadenylation | 0.00878397215086816 |
GO:0009117 | nucleotide metabolic process | 0.00920670492014003 |
GO:0004329 | formate-tetrahydrofolate ligase activity | 0.00920670492014003 |
GO:0006144 | purine base metabolic process | 0.00920670492014003 |
GO:0006139 | nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0101610744609576 |
GO:0055086 | nucleobase, nucleoside and nucleotide metabolic process | 0.0101610744609576 |
GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 0.0101946355089543 |
GO:0043631 | RNA polyadenylation | 0.0103962941467483 |
GO:0009086 | methionine biosynthetic process | 0.0103962941467483 |
GO:0009077 | histidine family amino acid catabolic process | 0.0103962941467483 |
GO:0006548 | histidine catabolic process | 0.0103962941467483 |
GO:0051668 | localization within membrane | 0.0103962941467483 |
GO:0005634 | nucleus | 0.0104898718485841 |
GO:0031124 | mRNA 3'-end processing | 0.0106702538866237 |
GO:0046112 | nucleobase biosynthetic process | 0.0106702538866237 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 0.0120048467004822 |
GO:0009067 | aspartate family amino acid biosynthetic process | 0.0125607805918415 |
GO:0030530 | heterogeneous nuclear ribonucleoprotein complex | 0.0129073440839092 |
GO:0006555 | methionine metabolic process | 0.0129073440839092 |
GO:0031123 | RNA 3'-end processing | 0.0133568403480145 |
GO:0006547 | histidine metabolic process | 0.0133568403480145 |
GO:0009075 | histidine family amino acid metabolic process | 0.0133568403480145 |
GO:0000097 | sulfur amino acid biosynthetic process | 0.0133568403480145 |
GO:0003727 | single-stranded RNA binding | 0.0133568403480145 |
GO:0032991 | macromolecular complex | 0.0143517521129979 |
GO:0005654 | nucleoplasm | 0.0146921544393844 |
GO:0009112 | nucleobase metabolic process | 0.0147501284471468 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 0.0147509141632119 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 0.0147509141632119 |
GO:0030532 | small nuclear ribonucleoprotein complex | 0.0147509141632119 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 0.0147509141632119 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 0.0147509141632119 |
GO:0043229 | intracellular organelle | 0.0147509141632119 |
GO:0043226 | organelle | 0.0147509141632119 |
GO:0044249 | cellular biosynthetic process | 0.0153285431293036 |
GO:0005941 | unlocalized protein complex | 0.0153285431293036 |
GO:0044446 | intracellular organelle part | 0.0153285431293036 |
GO:0044422 | organelle part | 0.0153285431293036 |
GO:0009066 | aspartate family amino acid metabolic process | 0.0155011953877277 |
GO:0000096 | sulfur amino acid metabolic process | 0.0158730168833439 |
GO:0006405 | RNA export from nucleus | 0.0160580573782975 |
GO:0000245 | spliceosome assembly | 0.0160580573782975 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 0.0172794177673077 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 0.0172794177673077 |
GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor | 0.0176120875006243 |
GO:0016874 | ligase activity | 0.0177508126499261 |
GO:0048583 | regulation of response to stimulus | 0.0177508126499261 |
GO:0046148 | pigment biosynthetic process | 0.018313385097542 |
GO:0006997 | nuclear organization and biogenesis | 0.018313385097542 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 0.018313385097542 |
GO:0009123 | nucleoside monophosphate metabolic process | 0.018313385097542 |
GO:0009396 | folic acid and derivative biosynthetic process | 0.018313385097542 |
GO:0031981 | nuclear lumen | 0.0187839884277303 |
GO:0042440 | pigment metabolic process | 0.0198410709876166 |
GO:0042770 | DNA damage response, signal transduction | 0.0201163796120492 |
GO:0051168 | nuclear export | 0.0201940384489898 |
GO:0006760 | folic acid and derivative metabolic process | 0.0201940384489898 |
GO:0044272 | sulfur compound biosynthetic process | 0.0204581691664226 |
GO:0065003 | macromolecular complex assembly | 0.0211608155288724 |
GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 0.0218602066024701 |
GO:0009058 | biosynthetic process | 0.0227569158174758 |
GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors | 0.0227745621898682 |
GO:0019748 | secondary metabolic process | 0.0230032491780804 |
GO:0022607 | cellular component assembly | 0.0232599132872617 |
GO:0016831 | carboxy-lyase activity | 0.0238725883458216 |
GO:0003697 | single-stranded DNA binding | 0.0257665731809479 |
GO:0046907 | intracellular transport | 0.0281202584035222 |
GO:0043623 | cellular protein complex assembly | 0.0283847522894954 |
GO:0065002 | intracellular protein transport across a membrane | 0.0283847522894954 |
GO:0044424 | intracellular part | 0.0288803720298249 |
GO:0010467 | gene expression | 0.0302607832292535 |
GO:0031974 | membrane-enclosed lumen | 0.0302607832292535 |
GO:0043233 | organelle lumen | 0.0302607832292535 |
GO:0005515 | protein binding | 0.0319526487732182 |
GO:0016830 | carbon-carbon lyase activity | 0.0319526487732182 |
GO:0033036 | macromolecule localization | 0.0319526487732182 |
GO:0008652 | amino acid biosynthetic process | 0.0323185505394083 |
GO:0006790 | sulfur metabolic process | 0.0325652914814427 |
GO:0005643 | nuclear pore | 0.0325652914814427 |
GO:0009063 | amino acid catabolic process | 0.0326856938226464 |
GO:0009310 | amine catabolic process | 0.0350222804975169 |
GO:0044270 | nitrogen compound catabolic process | 0.0353154754539087 |
GO:0051649 | establishment of cellular localization | 0.0353154754539087 |
GO:0046930 | pore complex | 0.0353154754539087 |
GO:0051170 | nuclear import | 0.0354101628056411 |
GO:0051641 | cellular localization | 0.0362188448013473 |
GO:0030529 | ribonucleoprotein complex | 0.0366795809431643 |
GO:0044453 | nuclear membrane part | 0.0391841976045881 |
GO:0016043 | cellular component organization and biogenesis | 0.040027704534505 |
GO:0009309 | amine biosynthetic process | 0.041374638916086 |
GO:0006752 | group transfer coenzyme metabolic process | 0.0475581868919423 |
GO:0022618 | protein-RNA complex assembly | 0.0475588805752745 |
GO:0044271 | nitrogen compound biosynthetic process | 0.0495576642363756 |
GO:0009152 | purine ribonucleotide biosynthetic process | 0.0495576642363756 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br><br>disease_data<br>
Ontology term | p-value | n |
---|---|---|
animal cell | 3.05e-21 | 679 |
eukaryotic cell | 3.05e-21 | 679 |
epithelial cell | 1.07e-15 | 253 |
native cell | 9.21e-15 | 722 |
embryonic cell | 3.53e-08 | 250 |
Ontology term | p-value | n |
---|---|---|
disease of cellular proliferation | 2.60e-54 | 239 |
cancer | 2.82e-54 | 235 |
organ system cancer | 8.23e-27 | 137 |
cell type cancer | 3.65e-26 | 143 |
carcinoma | 2.49e-22 | 106 |
hematologic cancer | 4.15e-21 | 51 |
immune system cancer | 4.15e-21 | 51 |
leukemia | 4.55e-17 | 39 |
myeloid leukemia | 3.40e-13 | 31 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
BCLAF1#9774 | 4 | 9.62339893783193 | 0.000474887791394397 | 0.00433273399540835 |
BRCA1#672 | 4 | 8.97076917476612 | 0.000620269035673191 | 0.00514088388355467 |
CCNT2#905 | 5 | 3.52011198720146 | 0.00704556022641387 | 0.0293944499055822 |
CHD2#1106 | 6 | 6.89601522274457 | 5.28898897155739e-05 | 0.000897735607346794 |
E2F1#1869 | 8 | 4.3621237465594 | 2.18983367577486e-05 | 0.000480975897506311 |
E2F4#1874 | 6 | 8.44537354352296 | 1.64629101974599e-05 | 0.000380055233888707 |
E2F6#1876 | 7 | 3.90223223576463 | 0.000306742359949273 | 0.00316247436631216 |
ELF1#1997 | 7 | 3.31185396796142 | 0.000896020581017362 | 0.0066694813955436 |
EP300#2033 | 5 | 3.76330095901289 | 0.00524217846159075 | 0.024286380532763 |
ETS1#2113 | 6 | 6.48584061480156 | 7.51193928811803e-05 | 0.00116331469055718 |
GABPB1#2553 | 5 | 3.92649102010121 | 0.00433797609228731 | 0.0205858726418754 |
HEY1#23462 | 8 | 3.59120981609396 | 9.88548321897326e-05 | 0.00139216556351989 |
HMGN3#9324 | 5 | 4.54363762408366 | 0.00224461831902441 | 0.0128911571416327 |
IRF1#3659 | 6 | 5.09144250237593 | 0.000296360970332 | 0.00309392676734344 |
IRF3#3661 | 3 | 15.6606507371632 | 0.000735147872062502 | 0.00579326255265492 |
MAX#4149 | 6 | 4.30170367267141 | 0.000759756385172366 | 0.00596827356983954 |
MXI1#4601 | 7 | 7.74788904459056 | 3.07469224127045e-06 | 0.000103686723598981 |
MYC#4609 | 7 | 4.06177478902954 | 0.000235555679657337 | 0.00256797490894913 |
NFKB1#4790 | 6 | 3.65870894946256 | 0.00185064964860272 | 0.0109339819341755 |
NFYA#4800 | 3 | 6.14186023327684 | 0.0104816316305809 | 0.038817457744982 |
NFYB#4801 | 3 | 5.58659775117882 | 0.0135850027711194 | 0.0479503904969054 |
NRF1#4899 | 6 | 8.14018629847394 | 2.03653511272495e-05 | 0.000451674858012065 |
PAX5#5079 | 5 | 3.70531418398768 | 0.00561655707771942 | 0.0253901053819823 |
POLR2A#5430 | 8 | 1.90884726805162 | 0.011661228959883 | 0.0425804870757715 |
REST#5978 | 4 | 4.28890165161245 | 0.00945702594596283 | 0.0356641269867268 |
RFX5#5993 | 4 | 5.35462703430893 | 0.00424944502767474 | 0.0202208761274523 |
SIN3A#25942 | 7 | 4.20691034307844 | 0.000186784365617447 | 0.00226017522427535 |
SP1#6667 | 8 | 5.0652278916808 | 6.82787133058497e-06 | 0.000198412925402049 |
SP2#6668 | 3 | 8.7178434979482 | 0.00394553175057863 | 0.0189438851829111 |
TAF1#6872 | 8 | 2.97159669844026 | 0.000423374995123481 | 0.00395924616007354 |
TAF7#6879 | 6 | 7.62204626994928 | 2.97588074999805e-05 | 0.000616418107197633 |
TBP#6908 | 8 | 3.29490727741901 | 0.000191885322027247 | 0.00231546056004664 |
TRIM28#10155 | 3 | 6.19684168175417 | 0.010227806502978 | 0.0380827082378878 |
USF1#7391 | 6 | 4.24099951813864 | 0.000822001744194416 | 0.00626041275883618 |
YY1#7528 | 7 | 3.81979947210855 | 0.000352967281214194 | 0.00353641115528868 |
ZBTB33#10009 | 4 | 14.0732111244361 | 0.00011021168021743 | 0.00153186021695877 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.